|
R&D Systems
alexa fluor 488 conjugated anti cd45 Alexa Fluor 488 Conjugated Anti Cd45, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45+alexa+fluor+488/CD45+Antibody+(PTPRC%2F1975R)+%5BAlexa+Fluor%C2%AE+488%5D/pmc09052694-92-3-15 Average 96 stars, based on 1 article reviews
alexa fluor 488 conjugated anti cd45 - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
R&D Systems
fab1430g anti human c5ar ![]() Fab1430g Anti Human C5ar, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45+alexa+fluor+488/Human+CD45+Alexa+Fluor%C2%AE+488-conjugated+Antibody/pm29290576-207-89-85 Average 90 stars, based on 1 article reviews
fab1430g anti human c5ar - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Novus Biologicals
alexa fluor 488 conjugated rat monoclonal anti cd45 ![]() Alexa Fluor 488 Conjugated Rat Monoclonal Anti Cd45, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45+alexa+fluor+488/Mouse+CD45+Alexa+Fluor%C2%AE+488-conjugated+Antibody/pmc06875631-312-28-34 Average 92 stars, based on 1 article reviews
alexa fluor 488 conjugated rat monoclonal anti cd45 - by Bioz Stars,
2026-10
92/100 stars
|
Buy from Supplier |
|
R&D Systems
alexa fluor 488 anti mouse cd45 antibody ![]() Alexa Fluor 488 Anti Mouse Cd45 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45+alexa+fluor+488/Mouse+CD45+Alexa+Fluor%C2%AE+488-conjugated+Antibody/pmc12367945-88-38-56 Average 93 stars, based on 1 article reviews
alexa fluor 488 anti mouse cd45 antibody - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
nb100 77417af488 anti mouse cd45 novus biologicals ![]() Nb100 77417af488 Anti Mouse Cd45 Novus Biologicals, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45+alexa+fluor+488/CD45+Antibody+(30-F11)+%5BAlexa+Fluor%C2%AE+488%5D/pm32846130-197-76-79 Average 90 stars, based on 1 article reviews
nb100 77417af488 anti mouse cd45 novus biologicals - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
R&D Systems
mouse cd45 alexafluor 488 ![]() Mouse Cd45 Alexafluor 488, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45+alexa+fluor+488/Human+CD45+Alexa+Fluor%C2%AE+488-conjugated+Antibody/pmc06927560-21-0-3 Average 93 stars, based on 1 article reviews
mouse cd45 alexafluor 488 - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
IncellDx Inc
alexa fluor® 488 anti-cd45 antibody ![]() Alexa Fluor® 488 Anti Cd45 Antibody, supplied by IncellDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd45+alexa+fluor+488/alexa+fluor++488+anti+cd45+antibody/med_rxiv__2024__03__24__24304286-31-19-24 Average 90 stars, based on 1 article reviews
alexa fluor® 488 anti-cd45 antibody - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
The CD45 Antibody (136-4B5) [Alexa Fluor® 488] from Novus is a CD45 antibody to CD45. This antibody reacts with Human. The CD45 antibody has been validated for the following applications: Immunohistochemistry, Immunohistochemistry-Paraffin.
|
Buy from Supplier |
|
The CD45 Antibody (5C16) [Alexa Fluor® 488] from Novus is a CD45 antibody to CD45. This antibody reacts with Mouse. The CD45 antibody has been validated for the following applications: Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin.
|
Buy from Supplier |
|
The Mouse CD45 1 Alexa Fluor« 488 conjugated Antibody from R D Systems is a mouse monoclonal antibody to CD45 1 This antibody reacts with mouse The Mouse CD45 1 Alexa Fluor« 488 conjugated Antibody
|
Buy from Supplier |
|
The CD45 Antibody IBL 3 16 Alexa Fluor« 488 from Novus Biologicals is a rat monoclonal antibody to CD45 This antibody reacts with mouse The CD45 Antibody IBL 3 16 Alexa Fluor« 488 has been
|
Buy from Supplier |
|
The Mouse CD45 Alexa Fluor« 488 conjugated Antibody from R D Systems is a rat monoclonal antibody to CD45 This antibody reacts with mouse The Mouse CD45 Alexa Fluor« 488 conjugated Antibody has been validated
|
Buy from Supplier |
Image Search Results
Journal: Cell host & microbe
Article Title: Leukotriene B4-Mediated Neutrophil Recruitment Causes Pulmonary Capillaritis during Lethal Fungal Sepsis.
doi: 10.1016/j.chom.2017.11.009
Figure Lengend Snippet: Figure 2. Rapid PMN Intravascular Chemotaxis to Sequestered C. albicans Is Complement Dependent (A) Lung C5a levels were determined using ELISA in control and C3/ animals, following i.v. C. albicans. Two-way ANOVA, Sidak’s multiple comparison. (B) Using intravital microscopy, PMN chemotactic behaviors in C3/ and anti-C5aR mAb-treated mice were observed. Images shown are 10 min after C. albicans injection. Red arrows highlight yeast not recognized by PMN. Scale bar represents 30 mm. (C) Quantification of PMN chemotaxing to pathogens in C3/ and C5a receptor-blocked mice. One-way ANOVA, Dunnett’s multiple comparison. (D) The percentage of C. albicans phagocytosed during the initial 10 min of intravenous administration in control, C3/, and anti-C5aR mAb-treated mice using pulmonary intravital microscopy. t tests were used to compare C57BL/6 and anti-C5aR mAb treated (*) or C3/ (#) mouse time points. (E and F) C. albicans CFU was quantified in organs at (E) 1 hr and (F) 24 hr after injection with 1 3 106 C. albicans in mice treated with anti-C5a receptor antibodies or isotype. (G) Clinical sepsis scores of isotype and anti-C5aR mAb antibody treated mice 24 hr after injection with 1 3 106 C. albicans. A score of 21 is the clinical endpoint for euthanization. For (A)–(F), at least three individual experiments were performed; for (G) three individual experiments were performed. Error bars represent mean ± SEM. *p < 0.05, **p < 0.01.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-Ly6G (clone 1A8) BioLegend RRID: AB_2563207 (BioLegend Cat. No. 127636) Anti-CD31 (clone MEC13.3) BioLegend RRID: AB_2161030 (BioLegend Cat. No. 102515) Anti-CD45 (clone 30-F11) BioLegend RRID: AB_493532 (BioLegend Cat. No. 103121) Anti-CD49b (clone HMa2) BD Bioscience Catalog No. 558295 Anti-C5aR (CD88, clone 20/70) BioLegend RRID: AB_2067286 (BioLegend Cat. No. 135804) Purified anti-mouse Ly6G (clone 1A8) BioXCell BP0075-1 Anti-TER119 Biolegend RRID: AB_528961 (BioLegend Cat. No. 116218) Anti-human CD15 (clone W6D3) BioLegend RRID: AB_756018 (BioLegend Cat. No. 323012) Anti-human CD45 (clone 2D1)
Techniques: Chemotaxis Assay, Enzyme-linked Immunosorbent Assay, Control, Comparison, Intravital Microscopy, Injection
Journal: Cell host & microbe
Article Title: Leukotriene B4-Mediated Neutrophil Recruitment Causes Pulmonary Capillaritis during Lethal Fungal Sepsis.
doi: 10.1016/j.chom.2017.11.009
Figure Lengend Snippet: Figure 4. PMN Vascular Clustering during Candidemia Is Dependent on LTB4 In Vivo (A) PMN clustering (white) is compared among C57BL/6, C3/, and anti-C5aR mAb-treated mice following 1 hr of i.v. live C. albicans. Scale bar, 200 mm. (B and C) (B) Mean cluster area and (C) max skeletal length of clusters were compared. One-way ANOVA, Holm-Sidak’s multiple comparison. (D and E) Lung LTB4 levels of C57BL/6 and C3/ mice (D), two-way ANOVA, Holm-Sidak’s multiple comparison, and following anti-C5aR mAb-treated mice (E). (F) LTB4 in isolated pulmonary PMN with or without C. albicans infection (1 hr). Unpaired two-tailed t test. (G) A representative image of PMN clusters (white) in LTB4R/ mice following C. albicans (1 hr). Scale bar, 200 mm. (H and I) (H) Mean cluster area and (I) max. skeletal length of PMN clusters after C. albicans (1 hr). (J–L) 1 3 107 A488 zymosan or 1 3 107 A488 E. coli bioparticles (green) were injected i.v. during lung imaging. (J) Intravital images are shown at 60 min. Scale bar, 100 mm. Clusters were quantified as (K) max skeletal length and (L) mean cluster area. ANOVA was performed for panels with more than two groups, while unpaired two-tailed t test were used to compare two groups. n = at least 3 for each panel. Error bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-Ly6G (clone 1A8) BioLegend RRID: AB_2563207 (BioLegend Cat. No. 127636) Anti-CD31 (clone MEC13.3) BioLegend RRID: AB_2161030 (BioLegend Cat. No. 102515) Anti-CD45 (clone 30-F11) BioLegend RRID: AB_493532 (BioLegend Cat. No. 103121) Anti-CD49b (clone HMa2) BD Bioscience Catalog No. 558295 Anti-C5aR (CD88, clone 20/70) BioLegend RRID: AB_2067286 (BioLegend Cat. No. 135804) Purified anti-mouse Ly6G (clone 1A8) BioXCell BP0075-1 Anti-TER119 Biolegend RRID: AB_528961 (BioLegend Cat. No. 116218) Anti-human CD15 (clone W6D3) BioLegend RRID: AB_756018 (BioLegend Cat. No. 323012) Anti-human CD45 (clone 2D1)
Techniques: In Vivo, Comparison, Isolation, Infection, Two Tailed Test, Injection, Imaging
Journal: Cell host & microbe
Article Title: Leukotriene B4-Mediated Neutrophil Recruitment Causes Pulmonary Capillaritis during Lethal Fungal Sepsis.
doi: 10.1016/j.chom.2017.11.009
Figure Lengend Snippet: Figure 7. Anti-fungal Activity and Clustering of Human PMN Is Complement and LTB4 Dependent (A) Images of C5aR inhibition on PMN and C. albicans interactions in a human lung microvascular chamber (anti-C5aR-antibody 20 mg/mL). (B) C. albicans phagocytosis by PMN. (C) Residual immobilized but non-phagocytosed yeast PMN. (D and E) (D) Cluster formation and (E) the number of clustered PMN. (F) Images of LTB4R inhibition on PMN and C. albicans interactions in a human lung microvascular chamber. (G) Quantification of immobilized but non-phagocytosed yeast at 30 min. (H and I) (H) Clusters per field of view (FOV) and (I) PMN that were clustered per FOV were determined at 30 min. All data are expressed as mean ± SEM for n = 5–7. Student’s t tests were used to compare data between two groups. *p < 0.05 and **p < 0.01. All scale bars represent 20 mm.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-Ly6G (clone 1A8) BioLegend RRID: AB_2563207 (BioLegend Cat. No. 127636) Anti-CD31 (clone MEC13.3) BioLegend RRID: AB_2161030 (BioLegend Cat. No. 102515) Anti-CD45 (clone 30-F11) BioLegend RRID: AB_493532 (BioLegend Cat. No. 103121) Anti-CD49b (clone HMa2) BD Bioscience Catalog No. 558295 Anti-C5aR (CD88, clone 20/70) BioLegend RRID: AB_2067286 (BioLegend Cat. No. 135804) Purified anti-mouse Ly6G (clone 1A8) BioXCell BP0075-1 Anti-TER119 Biolegend RRID: AB_528961 (BioLegend Cat. No. 116218) Anti-human CD15 (clone W6D3) BioLegend RRID: AB_756018 (BioLegend Cat. No. 323012) Anti-human CD45 (clone 2D1)
Techniques: Activity Assay, Inhibition
Journal: Molecular Neurobiology
Article Title: High-Fat Diet-Induced Excessive Accumulation of Cerebral Cholesterol Esters and Microglial Dysfunction Exacerbate Alzheimer's Disease Pathology in APP NL−G−F mice
doi: 10.1007/s12035-025-05052-8
Figure Lengend Snippet: HFD feeding reduced TREM2 expression in microglia of APP NL–G–F mice brain. ( a - b ) Representative images of somatosensory cortex and hippocampus from APP NL–G–F mice fed an ND or an HFD for 27 weeks. Sections were stained with BAN50 (blue), IBA1 (green) and TREM2 (red). Scale bar = 50 μm. ( c - d ) Quantification of TREM2 immunofluorescence intensity of cortex and hippocampus from APP NL–G–F mice. Each dot represents an analyzed mouse, and 35 images were taken from each mouse brain for cortical analysis and 10 images were taken from each mouse brain for hippocampal analysis ( n = 4 mice per group). ( e – f ) Mean fluorescence intensity (MFI) graph of TREM2 + microglia isolated from cortex and hippocampus tissue samples from APP NL–G–F mice fed with ND or HFD for 27 weeks, as determined by flow cytometry with gating on CD45 and CD11b. ( g , j ) Percentage of CD45 + CD11b + cell population among all living single cells from the cortex and hippocampus tissue samples of APP NL–G–F mice. ( h , k ) Percentage of TREM2 + cell population within CD45 + CD11b + cell population from the cortex and hippocampus tissue samples of APP NL–G–F mice. ( i , l ) MFI of TREM2 in the CD45 + CD11b + population from the cortex and hippocampus tissue samples of APP . NL–G–F mice. Values are average ± SEM. Statistical analyses were performed using an unpaired t-test (* p < 0.05, ** p < 0.01; ns, not significant)
Article Snippet: After removing red blood cells and debris, cells were blocked with Fc Receptor Blocking Reagent (1: 100) for 15 min at room temperature and then stained with PE anti-mouse/human CD11b Antibody (1:50, BioLengend, Cat. No. 101208, Clone M1/70),
Techniques: Expressing, Staining, Immunofluorescence, Fluorescence, Isolation, Flow Cytometry
Journal: Cell reports
Article Title: BIRC2 Expression Impairs Anti-Cancer Immunity and Immunotherapy Efficacy.
doi: 10.1016/j.celrep.2020.108073
Figure Lengend Snippet: Figure 6. BIRC2 Knockdown in B16F10 Cells Increases Anti-tumor Immunity by Increasing CXCL9 Expression (A) NTC and BIRC2-KD subclones were implanted into C57BL/6 mice. When BIRC2-KD tumors became palpable, mice were treated with anti-CXCL9 or IgG every 3 days. Tumor volumes were determined (mean ± SEM; n = 4); *p < 0.05 (Kruskal-Wallis test with Benjamini-Hochberg post-test). (B–E) Tumors were harvested on day 35, and the percentage of CD8+ T cells (relative to CD45+ population) (B), CD8+/CD44+/CD69+ T cells (C), CD3/NK1.1+ NK cells (D), and CD11b+/CD11c+/F4/80 DCs (E) was determined (mean ± SEM; n = 4); *p < 0.05 (Kruskal-Wallis test with Benjamini-Hochberg post-test). All immune cell populations (except B) were calculated as a percentage of the total live cells (based on forward and side scatter). (F–H) The Pearson correlation test was performed to compare CXCL9 mRNA expression with CD8+ T cell score (F), NK cell score (G), and DC score (H), using TCGA data from 481 human melanomas. See also Figures S3C and S4.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-mouse BIRC2 Novus Biologicals Cat# NB100-56889 Anti-mouse b-Actin Santa Cruz Biotechnology Cat# sc-47778 Anti-mouse CD3 BioLegend Cat# 102102 Anti-mouse CD3 Novus Biologicals Cat# FAB4841G-100 Anti-mouse CD4 Novus Biologicals Cat# FAB554A-100 Anti-mouse CD8A Novus Biologicals Cat# NBP1-49045PE Anti-mouse CD11b Novus Biologicals Cat# NB110-89474AF405 Anti-mouse CD11c Novus Biologicals Cat# NB110-40766AF488 Anti-mouse CD25 Novus Biologicals Cat# NBP2-27425AF488 Anti-mouse CD28 BioLegend Cat# 100223 Anti-mouse CD44 Novus Biologicals Cat# NBP1-47386APC Anti-mouse CD45 Novus Biologicals Cat#
Techniques: Knockdown, Expressing